The popularity of psychedelic fungi transcends their recreational and medical benefits. They’re entering the world of “suburban chic.” Read More
Analyst Articles
The coronavirus is generating wild swings in the markets, but this winning strategy reaps profits regardless of ups and downs. Read More
The rally has stalled, as investors face a litany of unavoidable threats. Wall Street is finally acknowledging that the pandemic can't be wished away. Read More
A second wave of coronavirus is clobbering investors and weighing on stocks. Take these defensive measures now. Read More
We interviewed our in-house Sinologist for his insights into the pandemic, U.S-China trade tensions, the deep global recession, and more. Read More
A movement is gaining traction to normalize laws not just for marijuana but also many other psychoactive substances. The potential profits are huge. Read More
The Federal Reserve’s latest expression of policy presents a mixed bag of news that’s fueling investor uncertainty. Here's what it all means. Read More
"Positive" economic data could be planting the seeds of future disaster for the stock market. Here are investment moves to make now. Read More
Advocates for decriminalizing “magic mushrooms” are gaining political clout. The money-making ramifications for investors are huge. Read More
Investors are cheering an economic "rebound" that’s a façade. Here’s why you should be skeptical of the stock market rally. Read More